Moody’s affirms Holy Name Medical Center’s ‘Baa2’ rating

Moody’s Investors Service has affirmed the “Baa2” rating on Teaneck, N.J.-based Holy Name Medical Center’s $106.9 million of outstanding debt.

Advertisement

The rating affirmation is based on several factors, including Holy Name’s solid market position, consistent operating performance and strong revenue growth.

The medical center also faces numerous challenges, including its location in the highly competitive New Jersey market.

The outlook is stable, reflecting Moody’s expectation that Holy Name will maintain stable liquidity and continue to show consistent operating performance.

More articles on healthcare finance:
In pay-for-performance, are hospitals unfairly penalized for patient hardships?
Financial pains of patient accounting systems felt most in the first three months: 7 findings
Medicare Advantage sign-ups surge, defy expectations: 3 things to know

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.